FDA Responds to Creative Medical Technology Holdings Regarding Its ImmCelz® IND for Stroke Treatment
- Friday, May 14, 2021, 7:04
- Finance
- Add a comment
PHOENIX, May 14, 2021 /PRNewswire/ — Creative Medical Technology Holdings Inc., trading under ticker symbol CELZ, announced today receipt of detailed correspondence from the FDA regarding necessary modifications to IND #27375 for using ImmCelz® regenerative immunotherapy for the…
About the Author
adminasapcorp has written 41811 stories on this site.